A mobile sleep program to help teens with high blood pressure sleep longer
Official title: Sleep Promotion Among Children Newly Diagnosed With Essential Hypertension
Run by Children's Hospital of Philadelphia · NCT06642246 · Data updated 2026-11-12
This trial tries a phone/computer-based sleep extension program for 13-to-18-year-olds with recently diagnosed high blood pressure to see if they sleep more and their blood pressure goes down.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 18 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Children's Hospital of Philadelphia Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | February 16, 2026 |
| Main results expected | November 2026 |
| Study ends | November 2026 |
| Registry record updated | August 28, 2026 |
| Trial ID | NCT06642246 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 13–18 year-olds with a recent diagnosis of essential hypertension managed initially with lifestyle changes, who report ≤7.5 hours in bed per night, have internet or cellular access, and do not have a diagnosed sleep disorder.
✕Probably not a fit
Children with a diagnosed sleep disorder, those taking prescription antihypertensive or other blood-pressure–affecting medications, or those without reliable internet/phone access are unlikely to qualify or benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-site, home-based feasibility trial at the Children's Hospital of Philadelphia enrolling 10 adolescents (five parent-child dyads) aged 13–18 with recently diagnosed essential hypertension who currently spend ≤7.5 hours in bed on school nights. After a two-week run-in to capture baseline sleep using a provided sleep tracker and a home sleep polysomnography for clinical data, participants enter a seven-week intervention delivered via REDCap. The intervention is a mobile health sleep promotion platform aimed at extending sleep duration while avoiding participants with known clinical sleep disorders or current antihypertensive therapy. Primary outcomes include change in sleep duration and changes in systolic and diastolic blood pressure, along with feasibility metrics for delivering the program in a pediatric nephrology setting.
Why it matters
Potential benefit: If successful, this mobile sleep program could help teens increase nightly sleep and potentially lower blood pressure without starting medication.
How similar studies have gone: Prior research links sleep extension to blood pressure improvements in some populations, but using a mobile sleep-extension platform specifically in pediatric hypertension care is relatively novel and largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Speak, read and write in English. * Parental/guardian permission (informed consent) and child assent. * Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan. * Parent reported sleep duration on school nights less than or equal to 7.5 hours. * Recently diagnosed with essential hypertension by Ambulatory Blood Pressure Monitoring (ABPM). * If taking over the counter sleep aides, willing to stop them over the course of the study. Exclusion Criteria: * Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide. * Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnoses known to be associated with elevated blood pressure (e.g., cardiac disease, kidney disease or diabetes). Inclusion Criteria for Parents/Legal Guardians: * Be the parent/guardian of an eligible child enrolled in the main study. * Speak, read, and write in English. Exclusion Criteria for Parents/Legal Guardians: \- Limited English proficiency
Where it's running
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Jonathan Mitchell, PhD — Children's Hospital of Philadelphia
- Study coordinator: Jonathan Mitchell
- Email: mitchellj2@chop.edu
- Phone: 267-426-1473
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.